A Canadian Cost Impact Analysis Comparing Maintenance Therapy with Bortezomib Versus Lenalidomide in Multiple Myeloma Patients Ineligible for Stem Cell Transplant
May 1, 2014, 00:00
10.1016/j.jval.2014.03.446
https://www.valueinhealthjournal.com/article/S1098-3015(14)00497-5/fulltext
Title :
A Canadian Cost Impact Analysis Comparing Maintenance Therapy with Bortezomib Versus Lenalidomide in Multiple Myeloma Patients Ineligible for Stem Cell Transplant
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00497-5&doi=10.1016/j.jval.2014.03.446
First page :
A76
Section Title :
Cancer
Open access? :
No
Section Order :
1492